Neoadjuvant Dabrafenib + Trametinib for AJCC Stage IIIB-C BRAF V600 Mutation Positive Melanoma
Clinical trial NCT01972347 · COMPLETED
Trial details
- NCT number
- NCT01972347
- Sponsor
- Melanoma Institute Australia
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2017-05-04
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.